COMP <GO>
EMBC vs ABBV // GROSS PROFIT MARGIN
Embecta Corp. (NASDAQ) VS. AbbVie Inc. (NYSE) • 15-METRIC TALLY: EMBC 5
— ABBV 5
▲ GROSS PROFIT MARGIN LEADER: ABBV
LAST: $6.56 (+1.55%) • MKT CAP: $371.7M
gross-margins
62.60%
LAST: $290.79 (+1.68%) • MKT CAP: $513.86B
gross-margins
70.20%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (EMBC VS. ABBV)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | EMBC | ABBV | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin ACTIVE | 62.60% | 70.20% | -7.60 | ABBV | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 35.50% | 29.00% | +6.50 | EMBC | /roic <GO> |
| EV/EBITDA & P/E Valuation | 6.1x | 33.3x | -27.20 | EMBC | /valuation <GO> |
| Free Cash Flow Yield | — | 3.47% | — | TIE | /fcf-yield <GO> |
| Operating Margin | 22.40% | 24.60% | -2.20 | ABBV | /operating-margins <GO> |
| Net Profit Margin | 8.80% | 6.90% | +1.90 | EMBC | /net-margins <GO> |
| Revenue Growth (YoY) | -3.80% | 8.60% | -12.40 | ABBV | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 9.42% | 2.27% | +7.15 | EMBC | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 5.33 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 52.2 | 65.1 | -12.91 | ABBV | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.15 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 3.6x | 113.1x | -109.50 | EMBC | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $371.7M | $513.86B | -$513.49B | ABBV | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | EMBC REV | ABBV REV | EMBC GROSS % | ABBV GROSS % | EMBC FCF | ABBV FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.08B | $61.16B | 62.6% | 70.2% | $182.4M | $17.82B |
| FY 2024 | $1.12B | $56.33B | 65.5% | 70.0% | $19.9M | $17.83B |
| FY 2023 | $1.12B | $54.32B | — | — | $67.7M | $20.39B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
EMBC // BETA —
ABBV // BETA 1.15